Role of Echocardiography in the Management of Cardiac Disease in Women

키워드

참고문헌 (62)

1. Statistics Korea, "2013 Death statistics", Statistics Korea, ~ (2014)
2. Bilhartz TD, "Making use of a natural stress test : pregnancy and cardiovascular risk", J Womens Health(Larchmt), 20, pp.695~701 (2011)
3. Miller VM, "Sex-specific risk of cardiovascular disease and cognitive decline : pregnancy and menopause", Biol Sex Differ, 4, pp.6~ (2013)
4. Wenger NK, "Gender disparity in cardiovascular disease: bias or biology?", Expert Rev Cardiovasc Ther, 10, pp.1401~1411 (2012)
5. Ain DL, "Cardiovascular imaging and diagnostic procedures in pregnancy", Cardiol Clin, 30, pp.331~341 (2012)
6. Savu O, "Morphological and functional adaptation of the maternal heart during pregnancy", Circ Cardiovasc Imaging, 5, pp.289~297 (2012)
7. Cornette J, "Hemodynamic adaptation to pregnancy in women with structural heart disease", Int J Cardiol, 168, pp.825~831 (2013)
8. Bamfo JE, "Maternal left ventricular diastolic and systolic long-axis function during normal pregnancy", Eur J Echocardiogr, 8, pp.360~368 (2007)
9. Sliwa K, "Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy", Eur J Heart Fail, 12, pp.767~778 (2010)
10. Karaye KM, "Peripartum cardiomyopathy : a review article", Int J Cardiol, 164, pp.33~38 (2013)
11. Elkayam U, "Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management", J Am Coll Cardiol, 58, pp.659~670 (2011)
12. Goland S, "Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy", J Card Fail, 17, pp.426~430 (2011)
13. Vitarelli A, "Role of echocardiography in the assessment and management of adult congenital heart disease in pregnancy", Int J Cardiovasc Imaging, 27, pp.843~857 (2011)
14. Siu SC, "Prospective multicenter study of pregnancy outcomes in women with heart disease", Circulation, 104, pp.515~521 (2001)
15. Brickner ME, "Cardiovascular management in pregnancy : congenital heart disease", Circulation, 130, pp.273~282 (2014)
16. European Society of Gynecology (ESG), "ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)", Eur Heart J, 32, pp.3147~3197 (2011)
17. Asfour V, "Is vaginal delivery or caesarean section the safer mode of delivery in patients with adult congenital heart disease?", Interact Cardiovasc Thorac Surg, 17, pp.144~150 (2013)
18. Omnes S, "Pregnancy outcomes among women with Marfan syndrome", Int J Gynaecol Obstet, 122, pp.219~223 (2013)
19. Lotrionte M, "Review and meta-analysis of incidence and clinical predictors of anthracycline cardiotoxicity", Am J Cardiol, 112, pp.1980~1984 (2013)
20. Nolan MT, "Chemotherapy-related cardiomyopathy : a neglected aspect of cancer survivorship", Intern Med J, 44, pp.939~950 (2014)
21. Lipshultz SE, "Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association", Circulation, 128, pp.1927~1995 (2013)
22. Curigliano G, "Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines", Ann Oncol, 23(Suppl 7), pp.vii155~vii166 (2012)
23. Telli ML, "Trastuzumab-related cardiotoxicity : calling into question the concept of reversibility", J Clin Oncol, 25, pp.3525~3533 (2007)
24. Choueiri TK, "Congestive heart failure risk in patients with breast cancer treated with bevacizumab", J Clin Oncol, 29, pp.632~638 (2011)
25. Kalam K, "Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy : a systematic review and meta-analysis", Eur J Cancer, 49, pp.2900~2909 (2013)
26. Sawaya H, "Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab", Circ Cardiovasc Imaging, 5, pp.596~603 (2012)
27. Truong J, "Chemotherapy-induced cardiotoxicity: detection, prevention, and management", Can J Cardiol, 30, pp.869~878 (2014)
28. Altena R, "Cardiovascular toxicity caused by cancer treatment : strategies for early detection", Lancet Oncol, 10, pp.391~399 (2009)
29. Thavendiranathan P, "Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes : application to patients undergoing cancer chemotherapy", J Am Coll Cardiol, 61, pp.77~84 (2013)
30. Villarraga HR, "Cardio-oncology : role of echocardiography", Prog Cardiovasc Dis, 57, pp.10~18 (2014)
31. Thavendiranathan P, "Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review", J Am Coll Cardiol, 63(25 Pt A), pp.2751~2768 (2014)
32. Lotrionte M, "Temporal changes in standard and tissue Doppler imaging echocardiographic parameters after anthracycline chemotherapy in women with breast cancer", Am J Cardiol, 112, pp.1005~1012 (2013)
33. "Morbidity and mortality: 2012 chart book on cardiovascular, lung, and blood diseases" (2012)[URL]
34. Ford ES, "Explaining the decrease in U.S. deaths from coronary disease, 1980-2000", N Engl J Med, 356, pp.2388~2398 (2007)
35. de Boer SP, "Excess mortality in women compared to men after PCI in STEMI: an analysis of 11,931 patients during 2000-2009", Int J Cardiol, 176, pp.456~463 (2014)
36. Vaccarino V, "Sex differences in mortality after acute myocardial infarction : changes from 1994 to 2006", Arch Intern Med, 169, pp.1767~1774 (2009)
37. Noninvasive technologies for the diagnosis of coronary artery disease in women: future research needs: identification of future research needs from comparative effectiveness review No. 58, "Sanders GD", Agency for Healthcare Research and Quality (US), ~, pp.13-EHC072-EF (2013)
38. Wenger NK, "Women and coronary heart disease: a century after Herrick: understudied, underdiagnosed, and undertreated", Circulation, 126, pp.604~611 (2012)
39. Shaw LJ, "Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies", J Am Coll Cardiol, 47(3 Suppl), pp.S4~S20 (2006)
40. Gulati M, "Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease : a report from the Women’s Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project", Arch Intern Med, 169, pp.843~850 (2009)
41. Kwok Y, "Meta-analysis of exercise testing to detect coronary artery disease in women", Am J Cardiol, 83, pp.660~666 (1999)
42. Gulati M, "Prognostic value of the duke treadmill score in asymptomatic women", Am J Cardiol, 96, pp.369~375 (2005)
43. Alexander KP, "Value of exercise treadmill testing in women", J Am Coll Cardiol, 32, pp.1657~1664 (1998)
44. Shaw LJ, "Impact of gender on risk stratification by exercise and dobutamine stress echocardiography : long-term mortality in 4234 women and 6898 men", Eur Heart J, 26, pp.447~456 (2005)
45. Marwick TH, "Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women", J Am Coll Cardiol, 26, pp.335~341 (1995)
46. Vavas E, "Noninvasive diagnostic techniques for coronary disease in women", Clin Cardiol, 35, pp.149~155 (2012)
47. Mieres JH, "Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association", Circulation, 111, pp.682~696 (2005)
48. Dodi C, "The incremental prognostic value of pharmacological stress echo over exercise electrocardiography in women with chest pain of unknown origin", Eur Heart J, 22, pp.145~152 (2001)
49. Arruda-Olson AM, "Prognostic value of exercise echocardiography in 5,798 patients: is there a gender difference?", J Am Coll Cardiol, 39, pp.625~631 (2002)
50. Metz LD, "The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography : a meta-analysis", J Am Coll Cardiol, 49, pp.227~237 (2007)
51. Shaw LJ, "Evaluation of suspected ischemic heart disease in symptomatic women", Can J Cardiol, 30, pp.729~737 (2014)
52. Câmara EJ, "Baseline echocardiographic predictors of dynamic intraventricular obstruction of the left ventricle during dobutamine stress echocardiogram", Echocardiography, 26, pp.1195~1203 (2009)
53. Dawn B, "Left ventricular outflow tract obstruction provoked during dobutamine stress echocardiography predicts future chest pain, syncope, and near syncope", Am Heart J, 149, pp.908~916 (2005)
54. Pellikka PA, "Dynamic intraventricular obstruction during dobutamine stress echocardiography", Circulation, 86, pp.1429~1432 (1992)
55. Bairey Merz CN, "Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease", J Am Coll Cardiol, 47(3 Suppl), pp.S21~S29 (2006)
56. Shaw LJ, "Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry", Circulation, 117, pp.1787~1801 (2008)
57. Pepine CJ, "Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women’s Ischemia Syndrome Evaluation) study", J Am Coll Cardiol, 55, pp.2825~2832 (2010)
58. Dhawan SS, "Coronary microvascular dysfunction is associated with higher frequency of thin-cap fibroatheroma", Atherosclerosis, 223, pp.384~388 (2012)
59. Nihoyannopoulos P, "Absence of myocardial dysfunction during stress in patients with syndrome X", J Am Coll Cardiol, 18, pp.1463~1470 (1991)
60. Picano E, "Usefulness of a high-dose dipyridamole-echocardiography test for diagnosis of syndrome X", Am J Cardiol, 60, pp.508~512 (1987)
61. Prescott E, "Improving diagnosis and treatment of women with angina pectoris and microvascular disease : the iPOWER study design and rationale", Am Heart J, 167, pp.452~458 (2014)
62. Cadeddu C, "Altered transmural contractility in postmenopausal women affected by cardiac syndrome X", J Am Soc Echocardiogr, 27, pp.208~214 (2014)

관련 논문AI추천